Atinum Investment Co., Ltd. (KOSDAQ:021080)
South Korea · Delayed Price · Currency is KRW 2,160.00
-30.00 (-1.37%)
At close: Sep 10, 2026
Atinum Investment Revenue
Atinum Investment had revenue of 3.46B KRW in the quarter ending September 30, 2013, with 193.07% growth. This brings the company's revenue in the last twelve months to 8.92B, up 7.48% year-over-year. In the year 2012, Atinum Investment had annual revenue of 5.67B, down -42.95%.
Revenue (ttm)
8.92B
Revenue Growth
+7.48%
P/S Ratio
11.38
Revenue / Employee
524.67M
Employees
17
Market Cap
101.51B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2012 | 5.67B | -4.27B | -42.95% |
| Dec 31, 2011 | 9.94B | 3.50B | 54.40% |
| Dec 31, 2010 | 6.44B | -225.00M | -3.38% |
| Dec 31, 2009 | 6.66B | -61.43B | -90.22% |
| Dec 31, 2008 | 68.09B | -3.39B | -4.74% |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DASAN Networks | 572.04B |
| NAMU AX | 139.65B |
| Gridwiz | 118.82B |
| SM Culture & Contents | 110.37B |
| OPTUS Pharmaceutical | 94.47B |
| Stormtec | 71.50B |
| Sewoon Medical | 66.53B |
| Raonsecure | 60.56B |
Atinum Investment News
- 1 year ago - Samsung Backs Scholarly AI Bot Serving Students and Academics - BNN Bloomberg